Fundraising Fox

Humboldt

New York · Pre-Seed–Series A · 3 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Exclusive synthetic biology investor focused on companies replacing industrial inputs with biology-based alternatives, led by a UCSF-trained PhD cell biologist offering deep research expertise and global Latin America–Europe reach.

Stage
Pre-Seed–Series A
Check
$100K – $5M
HQ
New York, CA, US
Leads rounds
Follows
Tracked investments
18

Team · 3 people

from the firm's website
Benjamin Quiroga· General Partnerin

Benjamin Quiroga, a business-trained co-founder based in Chile, partners with deeply technical co-GPs to give early-stage synthetic biology founders lab-savvy mentorship and commercial strategy while investing globally.

Francisco Dopazo· General Partnerin

Latino investor with engineering, data analytics and business training who combines consulting and biotech co-founder experience with managing >$2B in multi-asset portfolios and structuring $500M+ in commercial real estate.

Sebastian Bernales· General Partnerin

Sebastian Bernales, a Chilean former VP of Discovery Biology at Medivation who helped develop Xtandi before its $14B Pfizer acquisition, builds globally distributed biotech models and US–Latin America scientific ties.

What they invest in

from 8 of 18 portfolio companies

Biotech ×7AI & Machine Learning ×4Medical Devices ×3Deep Tech ×2AgTech ×1Climate Tech ×1FoodTech ×1Healthtech ×1

HQs:United States×3

Investments · 18 tracked

founders shown can be your intro path
Affinittxaffinittx.comin𝕏
Ansa Biotechnologiesansabio.comin𝕏

Ansa Biotechnologies develops an enzyme-based process to manufacture DNA, offering an alternative to the established chemical synthesis methods used in the industry.

BiotechHealthtechEmeryville, US

Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inJason T. Gammack(Executive Officer, Director)Yanniv T. Dorone(Director)Daniel T. Lin-Arlow(Executive Officer, Director)Chenny T. Zhang(Director)

Brightseed, Inc.brightseedbio.com
Cellino Biocellinobio.comin

Cellineobio develops cell engineering and bioprocess technology platforms.

AI & Machine LearningBiotechDeep TechMedical Devices

Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)

Debutdebutbiotech.comin

Debut combines artificial intelligence and biotechnology to develop novel skincare and haircare ingredients.

AI & Machine LearningBiotechDeep Tech

Endpointendpoint.healthin𝕏
Finch Therapeuticsfinchtherapeutics.comin𝕏

Finch is a microbiome therapeutics company that develops innovative microbiome assets designed from human microbiota transplantation studies, targeting a range of therapeutic areas.

BiotechMedical Devices

Finless Foodsfinlessfoods.comin
GC Therapeuticsgc-tx.comin𝕏

GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling.

AI & Machine LearningBiotechMedical DevicesCambridge, US

George Church(Co-Founder & Scientific Advisor)Parastoo Khoshakhlagh(Chief Executive Officer & Co-Founder)Alex Ng(Chief Innovation Officer & Co-Founder)

Geltorgeltor.comin𝕏
Meatablemeatable.com
Metagenomimetagenomi.coin
Mission Barnsmissionbarns.comin𝕏

Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.

Climate TechFoodTechBerkeley, US

Ilan Eitan Fischer(Executive Officer, Director)David Bowman(Director)

Mycoworksmycoworks.comin𝕏
PhageLabphage-lab.comin

Phage Lab develops solutions to address bacterial outbreaks using a One Health approach, bringing together around 100 scientists and professionals from multiple disciplines in animal health and microbiology.

AgTechAI & Machine LearningBiotech

Realizedmiroculus.com
Tierra Biosciencestierrabiosciences.com

Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.

Biotech

Frequently asked questions

What stage does Humboldt invest at?
Humboldt invests at the Pre-Seed, Seed, Series A stages.
What is Humboldt's typical check size?
Humboldt typically writes checks of $100K – $5M.
What sectors does Humboldt focus on?
Humboldt focuses on AgTech, AI & Machine Learning, Biotech, FoodTech, Healthtech, New Materials.
Where is Humboldt located?
Humboldt is headquartered in New York, US.
Does Humboldt lead rounds?
Humboldt typically participates in rounds rather than leading them.

Similar investors

Featured in lists